Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
USC/Norris Comprehensive Cancer Center and Hospital
1972
mi
from 43215
Los Angeles, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
USC/Norris Comprehensive Cancer Center and Hospital
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated:  10/1/2015
City of Hope Medical Group Inc
1965
mi
from 43215
Pasadena, CA
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Phase I/II Trial of ZD1839 (Iressa®), Trastuzumab (Herceptin®), and Docetaxel (Taxotere®) in Patients With erbB-2 (HER-2) Overexpressing, Stage IV Breast Carcinoma
Status: Enrolling
Updated: 10/1/2015
City of Hope Medical Group Inc
1965
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
Aging and Cancer Effects (ACE) Study
Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
394
mi
from 43215
Madison, WI
Aging and Cancer Effects (ACE) Study
Aging and Cancer: The Effects of Comorbidities on Cancer and it's Treatment
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Pycnogenol for the Treatment of Lymphedema
Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
394
mi
from 43215
Madison, WI
Pycnogenol for the Treatment of Lymphedema
Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Mercy Cancer Center at Mercy Medical Center
102
mi
from 43215
Canton, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Mercy Cancer Center at Mercy Medical Center
102
mi
from 43215
Canton, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Geauga Regional Hospital
144
mi
from 43215
Chardonr, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Geauga Regional Hospital
144
mi
from 43215
Chardonr, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Lake University Ireland Cancer Center
148
mi
from 43215
Mentor, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Lake University Ireland Cancer Center
148
mi
from 43215
Mentor, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
Southwest General Health Center
117
mi
from 43215
Middleburgh Heights, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
Southwest General Health Center
117
mi
from 43215
Middleburgh Heights, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
131
mi
from 43215
Orange Villager, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
131
mi
from 43215
Orange Villager, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
University Suburban Health Center
133
mi
from 43215
South Euclid, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
University Suburban Health Center
133
mi
from 43215
South Euclid, OH
Click here to add this to my saved trials
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated:  10/1/2015
UHHS Westlake Medical Center
117
mi
from 43215
Westlaker, OH
Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
Patient Perspectives on Sharing Family Medical Histories
Status: Enrolling
Updated: 10/1/2015
UHHS Westlake Medical Center
117
mi
from 43215
Westlaker, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Geauga Regional Hospital
126
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Geauga Regional Hospital
126
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Lake/University Ireland Cancer Center
141
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Lake/University Ireland Cancer Center
141
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
University Suburban Health Center
133
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
University Suburban Health Center
133
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
UHHS Chagrin Highlands Medical Center
131
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
UHHS Chagrin Highlands Medical Center
131
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Southwest General Health Center
117
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Southwest General Health Center
117
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
UHHS Westlake Medical Center
117
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
UHHS Westlake Medical Center
117
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated:  10/1/2015
Mercy Cancer Center at Mercy Medical Center
126
mi
from 43215
Cleveland, OH
Lapatinib Resistance in Patients With Breast Cancer
Study of Resistance Mechanisms Against Lapatinib in Patients With ErbB-2-Positive Breast Cancers
Status: Enrolling
Updated: 10/1/2015
Mercy Cancer Center at Mercy Medical Center
126
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
A Pilot Trial to Correlate Serum Levels of Calgranulin A and B With Estrogen Receptor Status Among Patients With Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer
A Pilot Trial to Correlate Serum Levels of Calgranulin A and B With Estrogen Receptor Status Among Patients With Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated:  10/1/2015
University Hospitals Seidman Cancer Center
129
mi
from 43215
Cleveland, OH
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated: 10/1/2015
University Hospitals Seidman Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated:  10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Physiology of Chemotherapy Induced Fatigue and Cognitive Dysfunction in Early Stage Breast Cancer
Status: Enrolling
Updated: 10/1/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
2097
mi
from 43215
Berkeley, CA
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
2097
mi
from 43215
Berkeley, CA
Click here to add this to my saved trials
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
1887
mi
from 43215
Palm Springs, CA
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
1887
mi
from 43215
Palm Springs, CA
Click here to add this to my saved trials
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated:  10/2/2015
Clinical Research Facility
481
mi
from 43215
New York, NY
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated: 10/2/2015
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated:  10/2/2015
Research Site
mi
from 43215
Bahía Blanca,
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
A Phase II Randomised, Double-Blind, Stratified, Multi-Centre Trial Comparing the Nolvadex 20 Mg And Placebo Combination To The Nolvadex 20 Mg and ZD1839 (IRESSA™) 250 MG Combination In Patients With Metastatic Breast Cancer And Estrogen Receptor (ER) and/or Progesterone (PR) Positive Tumours
Status: Enrolling
Updated: 10/2/2015
Research Site
mi
from 43215
Bahía Blanca,
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Comprehensive Cancer Institute
411
mi
from 43215
Huntsville, AL
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Comprehensive Cancer Institute
411
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
MBCCOP - Gulf Coast
702
mi
from 43215
Mobile, AL
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
MBCCOP - Gulf Coast
702
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Providence Alaska Medical Center
3101
mi
from 43215
Anchorage, AK
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Providence Alaska Medical Center
3101
mi
from 43215
Anchorage, AK
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Western Regional, Arizona
1662
mi
from 43215
Phoenix, AZ
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Western Regional, Arizona
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
1644
mi
from 43215
Scottsdale, AZ
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
1639
mi
from 43215
Tucson, AZ
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Breast Associates
655
mi
from 43215
Fayetteville, AR
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Breast Associates
655
mi
from 43215
Fayetteville, AR
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Surgical Associates
699
mi
from 43215
Fort Smith, AR
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Surgical Associates
699
mi
from 43215
Fort Smith, AR
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Northeast Arkansas Clinic
505
mi
from 43215
Jonesboro, AR
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Northeast Arkansas Clinic
505
mi
from 43215
Jonesboro, AR
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kaiser Permanente Medical Center - Anaheim/Orange County
1960
mi
from 43215
Anaheim, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kaiser Permanente Medical Center - Anaheim/Orange County
1960
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kaiser Permanente Medical Center - Baldwin Park
1956
mi
from 43215
Baldwin Park, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kaiser Permanente Medical Center - Baldwin Park
1956
mi
from 43215
Baldwin Park, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Kaiser Permanente Medical Center - Bellflower
1970
mi
from 43215
Bellflower, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Kaiser Permanente Medical Center - Bellflower
1970
mi
from 43215
Bellflower, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Alta Bates Comprehensive Cancer Center
2097
mi
from 43215
Berkeley, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Alta Bates Comprehensive Cancer Center
2097
mi
from 43215
Berkeley, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Providence Saint Joseph Medical Center - Burbank
1974
mi
from 43215
Burbank, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Providence Saint Joseph Medical Center - Burbank
1974
mi
from 43215
Burbank, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mills-Peninsula Health Services
2109
mi
from 43215
Burlingame, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mills-Peninsula Health Services
2109
mi
from 43215
Burlingame, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Enloe Cancer Center at Enloe Medical Center
2042
mi
from 43215
Chico, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Enloe Cancer Center at Enloe Medical Center
2042
mi
from 43215
Chico, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Mount Diablo Medical Center
2084
mi
from 43215
Concord, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Mount Diablo Medical Center
2084
mi
from 43215
Concord, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Corona Regional Medical Center
1941
mi
from 43215
Corona, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Corona Regional Medical Center
1941
mi
from 43215
Corona, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
City of Hope Comprehensive Cancer Center
1955
mi
from 43215
Duarte, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
City of Hope Comprehensive Cancer Center
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas
1949
mi
from 43215
Encinitas, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas
1949
mi
from 43215
Encinitas, CA
Click here to add this to my saved trials
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated:  10/5/2015
North Bay Cancer Center
2077
mi
from 43215
Fairfield, CA
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Status: Enrolling
Updated: 10/5/2015
North Bay Cancer Center
2077
mi
from 43215
Fairfield, CA
Click here to add this to my saved trials